GSDMD and metabolic dysfunction-associated steatotic liver disease: GSDMD-N has been found to be positively correlated with non-alcoholic steatohepatitis (AUC 0.74) and shows high accuracy in differentiating patients with non-alcoholic steatohepatitis and NAFLD (AUC 0.62), suggesting its potential as a biomarker [69].